BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bercu ZL, Fischman AM, Kim E, Nowakowski FS, Patel RS, Schiano TD, Chang CY, Lookstein RA. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol. 2015;204:654-661. [PMID: 25714299 DOI: 10.2214/ajr.14.12885] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsauo J, Li X. Viatorr TIPS Endoprosthesis Versus Generic Expanded Polytetrafluoroethylene-Covered Stent-Grafts. AJR Am J Roentgenol 2015;205:W463. [PMID: 26397354 DOI: 10.2214/AJR.15.14757] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Artru F, Moschouri E, Denys A. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: indications, technique, and outcomes beyond Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol 2022;:101858. [PMID: 34999250 DOI: 10.1016/j.clinre.2022.101858] [Reference Citation Analysis]
3 Yao X, Huang S, Zhou H, Tang SH, Qin JP. Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2021; 27(30): 5088-5099 [PMID: 34497437 DOI: 10.3748/wjg.v27.i30.5088] [Reference Citation Analysis]
4 Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol 2019; 25(28): 3738-3752 [PMID: 31391769 DOI: 10.3748/wjg.v25.i28.3738] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
5 Will V, Rodrigues SG, Berzigotti A. Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis. Dig Liver Dis 2022:S1590-8658(21)00894-X. [PMID: 35016859 DOI: 10.1016/j.dld.2021.12.007] [Reference Citation Analysis]
6 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9-29. [PMID: 33067334 DOI: 10.1136/gutjnl-2020-321790] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 47.0] [Reference Citation Analysis]
7 Chen Y, Qiu H, Zhang X. Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience. BMC Surg 2019;19:191. [PMID: 31830972 DOI: 10.1186/s12893-019-0659-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Yao X, Zhou H, Huang S, Tang SH, Qin JP. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis. World J Clin Cases 2021; 9(7): 1532-1542 [PMID: 33728297 DOI: 10.12998/wjcc.v9.i7.1532] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Banini BA, Alwatari Y, Stovall M, Ogden N, Gershman E, Shah RD, Strife BJ, Shojaee S, Sterling RK. Multidisciplinary Management of Hepatic Hydrothorax in 2020: An Evidence-Based Review and Guidance. Hepatology 2020;72:1851-63. [PMID: 32585037 DOI: 10.1002/hep.31434] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
10 Geeroms B, Laleman W, Laenen A, Heye S, Verslype C, van der Merwe S, Nevens F, Maleux G. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results. Eur Radiol 2017;27:1795-803. [PMID: 27629421 DOI: 10.1007/s00330-016-4570-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
11 Luo SH, Chu JG, Huang H, Yao KC. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2017; 23(26): 4779-4787 [PMID: 28765699 DOI: 10.3748/wjg.v23.i26.4779] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
12 Husnain SMN, Shojaee S. Hepatic Hydrothorax and Congestive Heart Failure Induced Pleural Effusion. Clin Chest Med 2021;42:625-35. [PMID: 34774170 DOI: 10.1016/j.ccm.2021.07.005] [Reference Citation Analysis]
13 Mukund A, Rana S, Mohan C, Kalra N, Baijal SS. Indian College of Radiology and Imaging Evidence-Based Guidelines for Interventions in Portal Hypertension and Its Complications. Indian J Radiol Imaging. [DOI: 10.1055/s-0041-1740235] [Reference Citation Analysis]